Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#40 / 40 Total
RAPT - RAPT Therapeutics Inc - Stock Price Chart
TickerRAPT [NASD, RUT]
CompanyRAPT Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap142.57MEPS (ttm)-3.07
P/E-EPS this Y4.62%
Forward P/E-EPS next Y20.74%
PEG-EPS past 5Y-12.39%
P/S-EPS next 5Y-
P/B1.09EPS Q/Q-3.35%
Dividend-Sales Q/Q-
Insider Own11.99%Inst Own81.60%
Insider Trans-0.12%Inst Trans-1.64%
Short Float10.53%EarningsMay 09/b
Analyst Recom2.33Target Price18.75
Avg Volume1.32M52W Range3.95 - 27.35
May-14-24 07:08AM Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform (MT Newswires) -9.09%
May-13-24 09:35AM Here's Why Rapt Therapeutics (RAPT) is Poised for a Turnaround After Losing -52.88% in 4 Weeks (Zacks)
May-10-24 03:46PM RAPT Therapeutics Inc. Reports Q1 2024 Earnings: A Detailed Financial Overview (GuruFocus.com) -7.08%
07:55AM Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy (MT Newswires)
07:54AM Barclays Downgrades RAPT Therapeutics to Equalweight, Price Target at $4 (MT Newswires)
May-09-24 04:12PM What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday? (Benzinga) -41.60%
03:59PM Sector Update: Health Care Stocks Higher Late Afternoon (MT Newswires)
02:31PM RAPT Therapeutics Shares Plunge After Wider Q1 Loss, Closing of Zelnecirnon Trials (MT Newswires)
01:53PM RAPT Stock Earnings: RAPT Therapeutics Beats EPS for Q1 2024 (InvestorPlace)
08:00AM RAPT Therapeutics Reports First Quarter 2024 Financial Results (GlobeNewswire)
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brockstedt Dirk G.CHIEF SCIENTIFIC OFFICERJan 05 '24Sale22.7889820,45627,820Jan 08 05:50 PM
Brockstedt Dirk G.Chief Scientific OfficerDec 29 '23Option Exercise6.188,00049,44027,070Jan 02 04:29 PM
HO WILLIAMChief Medical OfficerDec 21 '23Sale21.682,50054,20015,020Dec 22 02:31 PM
HO WILLIAMChief Medical OfficerNov 28 '23Sale13.721,50020,58017,520Nov 29 02:29 PM
HO WILLIAMChief Medical OfficerOct 03 '23Sale15.772,50039,42518,789Oct 04 06:29 PM
1234
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.